BridgeMD
New treatment option for Amyotrophic Lateral Sclerosis
Official title Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families
ClinicalTrials.gov ID: NCT05744310
What this study is testing
- What it's testing
- Amyotrophic lateral sclerosis (ALS) is a serious rapidly progressive disease of the nervous system. The average survival from the time of diagnosis is two to three years.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 and older. Healthy volunteers may be eligible.
You may be able to join if
- for patients:
- A clinical diagnosis of probable ALS according to the revised El Escorial criteria
- Progression of the illness leading the consulting physician to offer treatment with LTMV
- Can communicate in Norwegian for partners of ALS patients:
- Partner of a patient with ALS with progression of the illness leading the consulting physician to offer treatment with LTMV
You likely can't join if
- for patients, partners and children of ALS patients:
- 1\. Potential participants with cognitive impairment or dementia.
See the full eligibility criteria
- for patients:
- A clinical diagnosis of probable ALS according to the revised El Escorial criteria
- Progression of the illness leading the consulting physician to offer treatment with LTMV
- Can communicate in Norwegian for partners of ALS patients:
- Partner of a patient with ALS with progression of the illness leading the consulting physician to offer treatment with LTMV
- Can communicate in Norwegian for children:
- Children from 8 years and older having a parent who suffers from ALS with progression of the illness leading the consulting physician to offer treatment with LTMV
- Can communicate in Norwegian
- for patients, partners and children of ALS patients:
- 1\. Potential participants with cognitive impairment or dementia.
The study team makes the final eligibility decision.
Where it's taking place
- Bodø, Nordland, Norway
- Kristiansand, Vest Agder, Norway
- Bergen, Norway
- Lørenskog, Norway
- Oslo, Norway
- Sarpsborg, Norway
- Stavanger, Norway
- Tromsø, Norway
- Trondheim, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bodø, Nordland, Norway; Kristiansand, Vest Agder, Norway; Bergen, Norway; Lørenskog, Norway; Oslo, Norway; Sarpsborg, Norway and 3 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.